Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.
|Original language||English (US)|
|Number of pages||3|
|Journal||American Journal of Gastroenterology|
|State||Published - Jan 1 1993|
ASJC Scopus subject areas